Shareholder's request to convene a General Meeting of the Company and to include certain items on the agenda

Current report no. 58/2023

Date of the report: 07.12.2023

Subject: Shareholder's request to convene a General Meeting of the Company and to include certain items on the agenda.

Legal basis: Article 56(1)(2) of the Act on Offering - current and periodic information

The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the "Company") announces that today, i.e. 07.12.2023, it has received a request from Michał Walczak, a shareholder of the Company entitled from 955.128 shares of the Company representing 20.55% of the Company's share capital, to convene an Extraordinary General Meeting of the Company and to place certain matters on the agenda.

The request indicated the following proposed agenda:

1. Opening of the Extraordinary General Meeting.

2. Election of the Chairman of the Extraordinary General Meeting.

3. To declare that the Extraordinary General Meeting has been duly convened and is capable of passing binding resolutions.

4. Adoption of the agenda of the Extraordinary General Meeting.

5. Adoption of resolutions on changes to the composition of the Company’s Supervisory Board.

6. Adoption of a resolution on granting members of the Company's Supervisory Board the right to subscribe for shares in the Company as part of the Company's share-based incentive scheme.

7. Adoption of a resolution on incurring the costs of convening and holding the Extraordinary General Meeting by the Company.

8. Closing of the Extraordinary General Meeting.

The request received from a shareholder to convene an Extraordinary General Meeting of the Company, together with draft resolutions is attached as an appendix to this report.